Juan Vera - May 10, 2023 Form 4 Insider Report for Marker Therapeutics, Inc. (MRKR)

Role
President and CEO, Director
Signature
/s/ Michael Loiacono, Attorney-in-Fact
Stock symbol
MRKR
Transactions as of
May 10, 2023
Transactions value $
$0
Form type
4
Date filed
5/11/2023, 06:10 PM
Previous filing
Mar 1, 2023
Next filing
May 12, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRKR Employee Stock Option (right to buy) Award $0 +100K $0.00 100K May 10, 2023 Common Stock 100K $1.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in equal annual installments on May 10, 2024, May 10, 2025, May 10, 2026 and May 10, 2027 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.